...
首页> 外文期刊>Stem cells translational medicine. >Characterization and Angiogenic Potential of Human Neonatal and Infant Thymus Mesenchymal Stromal Cells
【24h】

Characterization and Angiogenic Potential of Human Neonatal and Infant Thymus Mesenchymal Stromal Cells

机译:人新生儿和婴儿胸腺间充质基质细胞的表征和血管生成潜力

获取原文
获取原文并翻译 | 示例

摘要

Resident mesenchymal stromal cells (MSCs) are involved in angiogenesis during thymus regeneration. We have previously shown that MSCs can be isolated from enzymatically digested human neonatal and infant thymus tissue that is normally discarded during pediatric cardiac surgical procedures. In this paper, we demonstrate that thymus MSCs can also be isolated by explant culture of discarded thymus tissue and that these cells share many of the characteristics of bone marrow MSCs. Human neonatal thymus MSCs are clonogenic, demonstrate exponential growth in nearly 30 population doublings, have a characteristic surface marker profile, and express pluripotency genes. Furthermore, thymus MSCs have potent proangiogenic behavior in vitro with sprout formation and angiogenic growth factor production. Thymus MSCs promote neoangiogenesis and cooperate with endothelial cells to form functional human blood vessels in vivo. These characteristics make thymus MSCs a potential candidate for use as an angiogenic cell therapeutic agent and for vascularizing engineered tissues in vitro.
机译:胸腺再生过程中常驻间充质基质细胞(MSCs)参与血管生成。先前我们已经表明,MSCs可从经酶消化的人类新生儿和婴儿胸腺组织中分离,而后者通常在儿科心脏外科手术过程中被丢弃。在本文中,我们证明了也可以通过废弃胸腺组织的外植体培养来分离胸腺MSC,并且这些细胞具有许多骨髓MSC的特征。人类新生儿胸腺MSC具有克隆性,在近30个种群倍增中显示出指数增长,具有特征性的表面标志物特征,并表达多能性基因。此外,胸腺间充质干细胞在体外具有有效的促血管生成作用,具有萌芽形成和血管生成生长因子产生。胸腺MSC促进新血管生成,并与内皮细胞协同作用,在体内形成功能性人血管。这些特性使胸腺MSCs有望用作血管生成细胞治疗剂并在体外使工程组织血管化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号